Shelly Fan in Singularity Hub:
Lights, vitamin, action. A combination of vitamin B2 and ultraviolet light hardly sounds like a next-generation cancer treatment. But a small new trial is testing the duo in people with recurrent ovarian cancer. Led by PhotonPharma, this first-in-humans study builds on decades of work investigating whether we can turn whole cancer cells into “vaccines.” Isolated from cancer patients, the cells are stripped of the ability to multiply but keep all other protein signals intact. Once reinfused, the cells can, in theory, alert the immune system that something is awry.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.